Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

This study has been completed.

Study NCT00234637 Information provided by Novartis

First Received: October 5, 2005 Last Updated: November 19, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2005
Estimated Primary Completion Date:	No date given